CME

Multidisciplinary Conversations on Paroxysmal Nocturnal Hemoglobinuria: How to Involve Patients in the Management of Their Disease

Authors: Richard Kelly, MBChB, PhD; Louise Arnold, RN; Jeff Szer, MBBS; Michael Brown, RN; Rachel Paine, Patient
CME Released: 2/27/2023
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 2/27/2024, 11:59 PM EST

Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US healthcare professionals involved in the management of PNH.

The goal of this activity is for learners to be better able to discuss the burden of suboptimal disease control and how to involve patients in the therapeutic decision-making process.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Remaining unmet needs in the management of PNH
- Burden of suboptimally controlled PNH on patients' quality of life
Demonstrate greater confidence in their ability to
- Implement shared decision-making regarding treatment selection for individual patients

Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.

Moderator

Richard Kelly, MBChB, PhD

Consultant Hematologist
Leeds Teaching Hospital NHS Trust
Leeds, United Kingdom

Disclosures

Richard Kelly, MBChB, PhD, has the following relevant financial relationships:
Consultant or advisor for: Alexion Pharmaceuticals, Inc; Amgen, Inc; Jazz Pharmaceuticals, Inc; Novartis; SOBI
Speaker or member of speakers bureau for: Alexion Pharmaceuticals, Inc; Astellas Pharma, Inc; Biologix; Jazz Pharmaceuticals, Inc; SOBI
Research funding from: Apellis Pharmaceuticals

Faculty

Louise Arnold, RN

Trainee Advanced Clinical Practitioner
Leeds Teaching Hospital NHS Trust
Leeds, United Kingdom

Disclosures

Louise Arnold, RN, has the following relevant financial relationships:
Consultant or advisor for: Alexion Pharmaceuticals, Inc; SOBI
Speaker or member of speakers bureau for: Alexion Pharmaceuticals, Inc; SOBI
Research funding from: Apellis Pharmaceuticals

Jeff Szer, MBBS

Professor, Department of Medicine (Royal Melbourne Hospital)
Faculty of Medicine, Health and Dentistry
The University of Melbourne
Clinical Hematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital
Melbourne, Victoria, Australia

Disclosures

Jeff Szer, MBBS, has the following relevant financial relationships:
Consultant or advisor for: Alexion Pharmaceuticals, Inc; Apellis Pharmaceuticals; BioCryst Pharmaceuticals, Inc; Eli Lilly and Company; Regeneron Pharmaceuticals, Inc; SOBI; Takeda
Speaker or member of speakers bureau for: Alexion Pharmaceuticals, Inc; Apellis Pharmaceuticals; SOBI; Takeda
Research funding from: Alexion Pharmaceuticals, Inc; Apellis Pharmaceuticals

Michael Brown, RN

Clinical Nurse Consultant
The Royal Melbourne Hospital
Melbourne, Victoria, Australia

Disclosures

Michael Brown, RN, has the following relevant financial relationships:
Consultant or advisor for: SOBI
Research funding from: Alexion Pharmaceuticals, Inc

Patient

Rachel Paine

Disclosures

Rachel Paine has no relevant financial relationships.

Editors

Sanneke Koekkoek

Medical Education Director, WebMD Global, LLC

Disclosures

Sanneke Koekkoek has no relevant financial relationships.

Chii Shyang Fong, PhD

Scientific Content Manager, WebMD Global, LLC

Disclosures

Chii Shyang Fong, PhD, has no relevant financial relationships.

Compliance Reviewer

Amanda Jett, PharmD, BCACP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Amanda Jett, PharmD, BCACP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education

CME

Multidisciplinary Conversations on Paroxysmal Nocturnal Hemoglobinuria: How to Involve Patients in the Management of Their Disease

Authors: Richard Kelly, MBChB, PhD; Louise Arnold, RN; Jeff Szer, MBBS; Michael Brown, RN; Rachel Paine, PatientFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME Released: 2/27/2023

Valid for credit through: 2/27/2024, 11:59 PM EST

processing....

Learning Feedback Questions

Please answer these questions to complement your learning experience.

Page 1 of 4

CME Information Download Slides

Activity Transcript

Print
Like Tweet

Activity Transcript

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Moderator

Richard Kelly, MBChB, PhD

Faculty

Louise Arnold, RN

Jeff Szer, MBBS

Michael Brown, RN

Patient

Rachel Paine

Editors

Sanneke Koekkoek

Chii Shyang Fong, PhD

Compliance Reviewer

Amanda Jett, PharmD, BCACP

Peer Reviewer

CME

Multidisciplinary Conversations on Paroxysmal Nocturnal Hemoglobinuria: How to Involve Patients in the Management of Their Disease

Target Audience and Goal Statement

Disclosures

Moderator

Richard Kelly, MBChB, PhD

Faculty

Louise Arnold, RN

Jeff Szer, MBBS

Michael Brown, RN

Patient

Rachel Paine

Editors

Sanneke Koekkoek

Chii Shyang Fong, PhD

Compliance Reviewer

Amanda Jett, PharmD, BCACP

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Multidisciplinary Conversations on Paroxysmal Nocturnal Hemoglobinuria: How to Involve Patients in the Management of Their Disease

Learning Feedback Questions